Biomarkers along the continuum of care in lung cancer

Circulating apoptotic markers in the management of non-small cell lung cancer

(2017) Stefan Holdenrieder et al.   Cancer Biomarkers

Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer

(2017) Stefan Holdenrieder et al.   Cancer Biomarkers

The American Cancer Society challenge goal to reduce US cancer mortality by 50% between 1990 and 2015: Results and reflections

(2016) Tim Byers et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China

(2015) Catharina M. Korse et al.   CLINICA CHIMICA ACTA

Circulating Tumor DNA Outperforms Circulating Tumor Cells for KRAS Mutation Detection in Thoracic Malignancies

(2015) M. B. Freidin et al.   CLINICAL CHEMISTRY

Circulating Tumor DNA as a Liquid Biopsy for Cancer

(2014) E. Heitzer et al.   CLINICAL CHEMISTRY

Current status of circulating protein biomarkers to aid the early detection of lung cancer

(2014) Carlos Enrique Hirales Casillas et al.   Future Oncology

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Liquid Biopsies: Genotyping Circulating Tumor DNA

(2014) Luis A. Diaz et al.   JOURNAL OF CLINICAL ONCOLOGY

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

Liquid biopsy: monitoring cancer-genetics in the blood

(2013) Emily Crowley et al.   Nature Reviews Clinical Oncology

Correlations between serial pro-gastrin-releasing peptide and neuron-specific enolase levels, and the radiological response to treatment and survival of patients with small-cell lung cancer

(2012) Akira Ono et al.   LUNG CANCER

EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays

(2012) Caroline J. Chapman et al.   TUMOR BIOLOGY

Increased plasma concentrations of tumour markers in the absence of neoplasia

(2011) Jaume Trapé et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Usefulness of Serum Tumor Markers, Including Progastrin-Releasing Peptide, in Patients with Lung Cancer: Correlation with Histology

(2009) Rafael Molina et al.   TUMOR BIOLOGY

Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer

(2008) S. Holdenrieder et al.   CLINICAL CANCER RESEARCH